Mannose-binding lectin deficiency attenuates renal changes in a streptozotocin-induced model of type 1 diabetes in mice

Diabetologia

Volumn 50, Issue 7, 2007, Pages 1541-1549

  Ostergaard J ^a   Thiel, S ^b   Gadjeva, M ^b   Hansen, T K ^a   Rasch, R ^a,b   Flyvbjerg, A ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Albumin excretion; Animal; Collagen; Complement; Diabetic angiopathy; Diabetic nephropathy; Kidney weight; Mannose binding lectin; Type 1 diabetes

Indexed keywords

COLLAGEN TYPE 4; INSULIN; MANNOSE BINDING LECTIN; MESSENGER RNA; STREPTOZOCIN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GLOMERULUS BASEMENT MEMBRANE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY MASS; KNOCKOUT MOUSE; MALE; MESANGIUM CELL; MOUSE; MOUSE STRAIN; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; WILD TYPE;

ALBUMINS; ANIMALS; COLLAGEN TYPE IV; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; KIDNEY; MALE; MANNOSE-BINDING LECTIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN SIZE; STREPTOZOCIN;

EID: 34249931038     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0686-0     Document Type: Article

References (47)

1. Hovind P, Tarnow L, Rossing K et al (2003) Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 26:1258-1264
2. Yokoyama H, Okudaira M, Otani T et al (2000) Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan. Kidney Int 58:302-311
3. Østergaard J, Hansen TK, Thiel S, Flyvbjerg A (2005) Complement activation and diabetic vascular complications. Clin Chim Acta 361:10-19
4. Hansen TK, Thiel S, Knudsen ST et al (2003) Elevated levels of mannan-binding lectin in patients with type 1 diabetes. J Clin Endocrinol Metab 88:4857-4861
5. Hansen TK, Tarnow L, Thiel S et al (2004) Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 53:1570-1576
6. Saraheimo M, Forsblom C, Hansen TK et al (2004) Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia 48:198-202
7. Hovind P, Hansen TK, Tarnow L et al (2005) Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort study. Diabetes 54:1523-1527
8. Shi L, Takahashi K, Dundee J et al (2004) Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 199:1379-1390
9. Jaffé M (1886) Uber den Niederschlag welchen Pikrinsäure in normalem Harn erzeugt und ueber eine neue Reaction des Kreatinins. Z Physiol Chem 10:391-400
10. Myers GL, Miller WG, Coresh J et al (2006) Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 52:5-18
11. Pagtalunan ME, Rasch R, Rennke HG, Meyer TW (1995) Morphometric analysis of effects of angiotensin II on glomerular structure in rats. Am J Physiol 268:F82-F88
12. Jensen EB, Gundersen HJ, Osterby R (1979) Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 115:19-33
13. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B (2004) Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 219:9-15
14. Turner MW (2003) The role of mannose-binding lectin in health and disease. Mol Immunol 40:423-429
15. Nordahl EA, Rydengard V, Nyberg P et al (2004) Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A 101:16879-16884
16. Thiel S, Frederiksen PD, Jensenius JC (2006) Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 43:86-96
17. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G (2003) Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88:1082-1088
18. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC (2000) Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 241:33-42
19. Schrijvers BF, De Vriese AS, Flyvbjerg A (2004) From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 25:971-1010
20. Hong SW, Isono M, Chen S, Iglesias-De La Cruz MC, Han DC, Ziyadeh FN (2001) Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 158:1653-1663
21. Pankewycz OG, Guan JX, Bolton WK, Gomez A, Benedict JF (1994) Renal TGF-beta regulation in spontaneously diabetic NOD mice with correlations in mesangial cells. Kidney Int 46:748-758
22. Sharma K, Jin Y, Guo J, Ziyadeh FN (1996) Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530
23. Riser BL, Denichilo M, Cortes P et al (2000) Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 11:25-38
24. Twigg SM, Cao Z, MCLennan SV et al (2002) Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology 143:4907-4915
25. van Nieuwenhoven FA, Jensen LJ, Flyvbjerg A, Goldschmeding R (2005) Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point? Nephrol Dial Transplant 20:6-10
26. Cha DR, Kang YS, Han SY et al (2004) Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. J Endocrinol 183:183-194
27. Cooper ME, Vranes D, Youssef S et al (1999) Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48:2229-2239
28. Senthil D, Choudhury GG, McLaurin C, Kasinath BS (2003) Vascular endothelial growth factor induces protein synthesis in renal epithelial cells: a potential role in diabetic nephropathy. Kidney Int 64:468-479
29. Tsuchida K, Makita Z, Yamagishi S et al (1999) Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195. Diabetologia 42:579-588
30. Yamamoto Y, Maeshima Y, Kitayama H et al (2004) Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 53:1831-1840
31. Amemiya T, Sasamura H, Mifune M et al (1999) Vascular endothelial growth factor activates MAP kinase and enhances collagen synthesis in human mesangial cells. Kidney Int 56:2055-2063
32. Thomas S, Vanuystel J, Gruden G et al (2000) Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. J Am Soc Nephrol 11:1236-1243
33. Hamano Y, Grunkemeyer JA, Sudhakar A et al (2002) Determinants of vascular permeability in the kidney glomerulus. J Biol Chem 277:31154-31162
34. Kawachi H, Koike H, Shimizu F (2002) mAb 5-1-6 nephropathy and nephrin. Microsc Res Tech 57:236-240
35. Wartiovaara J, Ofverstedt LG, Khoshnoodi J et al (2004) Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography. J Clin Invest 114:1475-1483
36. Kelly DJ, Aaltonen P, Cox AJ et al (2002) Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies. Nephrol Dial Transplant 17:1327-1332
37. Jensen LJ, Denner L, Schrijvers BF, Tilton RG, Rasch R, Flyvbjerg A (2006) Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice. J Endocrinol 188:493-501
38. Acosta J, Hettinga J, Fluckiger R et al (2000) Molecular basis for a link between complement and the vascular complications of diabetes. Proc Natl Acad Sci U S A 97:5450-5455
39. Benzaquen LR, Nicholson-Weller A, Halperin JA (1994) Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med 179:985-992
40. Uesugi N, Sakata N, Nangaku M et al (2004) Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation. Am J Kidney Dis 44:224-238
41. Qin X, Goldfine A, Krumrei N et al (2004) Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes. Diabetes 53:2653-2661
42. Granger CB, Mahaffey KW, Weaver WD et al (2003) Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the Complement Inhibition in Myocardial Infarction Treated with Angioplasty (COMMA) Trial. Circulation 108:1184-1190
43. Verrier ED, Shernan SK, Taylor KM et al (2004) Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA 291:2319-2327
44. Zimmerman JL, Dellinger RP, Straube RC, Levin JL (2000) Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome. Crit Care Med 28:3149-3154
45. Garred P, Madsen HO, Hofmann B, Svejgaard A (1995) Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet 346:941-943
46. Garred P, Madsen HO, Balslev U et al (1997) Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 349:236-240
47. Summerfield JA, Sumiya M, Levin M, Turner MW (1997) Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 314:1229-1232